(Q38852886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

title

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Herve Avet-Loiseau

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

23

Thierry Facon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

22

Paul G Richardson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

26

Philippe Moreau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

21

Kenneth C Anderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Valérie Lauwers-Cancès

2

object named as

Valerie Lauwers-Cances

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

20

Nikhil Munshi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

25

Jean-Luc Harousseau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

17

Michelle E Maglio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

13

Claire Mathiot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1

Michel Attal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

7

Bertrand Arnulf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

8

Margaret Macro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

9

Karim Belhadj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

10

Laurent Garderet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

15

Nathalie Meuleman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Martine Escoffre-Barbe

6

object named as

Martine Escoffre

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

12

Catherine Payen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

author name string

Denis Caillot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Jean P Fermand

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Sandrine Rollet

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Andrea A Zeytoonjian

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Edie A Weller

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

IFM 2009 Study

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Cyrille Hulin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Xavier Leleu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

language of work or name

English

0 references

publication date

1 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

number of pages

10

1 reference

The New England Journal of Medicine

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

1311-1320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

Current strategies for treatment of relapsed/refractory multiple myeloma

16 March 2020

cites work

1 reference

12 December 2020

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du

1 reference

12 December 2020

Assessment of minimal residual disease in myeloma and the need for a consensus approach

1 reference

12 December 2020

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study

1 reference

12 December 2020

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised p

1 reference

12 December 2020

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

1 reference

12 December 2020

Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.

1 reference

12 December 2020

A note on quantifying follow-up in studies of failure time

1 reference

12 December 2020

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

1 reference

12 December 2020

Lenalidomide after stem-cell transplantation for multiple myeloma

1 reference

12 December 2020

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

12 December 2020

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

1 reference

12 December 2020

Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms

1 reference

12 December 2020

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

1 reference

12 December 2020

Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies

1 reference

12 December 2020

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

1 reference

12 December 2020

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

1 reference

12 December 2020

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

1 reference

12 December 2020

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

1 reference

12 December 2020

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

12 December 2020

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

1 reference

12 December 2020

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

1 reference

12 December 2020

Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study

1 reference

12 December 2020

Autologous transplantation and maintenance therapy in multiple myeloma

1 reference

12 December 2020

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

1 reference

12 December 2020

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

1 reference

12 December 2020

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

1 reference

12 December 2020

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

1 reference

12 December 2020

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

12 December 2020

International uniform response criteria for multiple myeloma.

1 reference

12 December 2020

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

1 reference

12 December 2020

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

12 December 2020

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

12 December 2020

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

1 reference

12 December 2020

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

1 reference

12 December 2020

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

1 reference

12 December 2020

Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

1 reference

12 December 2020

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1611750

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28379796%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference